Symbol: |
LPP
|
Description: |
LIM domain containing preferred translocation partner in lipoma [Source:HGNC Symbol;Acc:6679]
|
Location: |
Chr3:187871072-188608460[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:382
Gene |
Compound |
Gen_sig |
Exp_pattern |
LPP |
NSC 105348 |
0.011 |
Down |
LPP |
Thiothixene |
0.001 |
Up |
LPP |
Lobinaline, monohydrochloride |
0.043 |
Up |
LPP |
NSC 116532 |
0.025 |
Up |
LPP |
NSC 11850 |
0.021 |
Up |
LPP |
NSC 11865 |
0.001 |
Up |
LPP |
NSC 119911 |
0.028 |
Up |
LPP |
Geldanamicin |
0.03 |
Up |
LPP |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.001 |
Up |
LPP |
NSC 128166 |
0.005 |
Up |
LPP |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.004 |
Up |
LPP |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.025 |
Up |
LPP |
NSC 13477 |
0.017 |
Up |
LPP |
NSC 135371 |
0.031 |
Up |
LPP |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.003 |
Up |
Expression pattern: Sensitivity / Resistance
Total:26 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:291
Total:20 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
|